logo

For the Inventor, By the Inventor

Manchester, MO, United States of America

Sekhar S Boddupalli

This inventor holds 14 USPTO granted patents and 2 published patent applications. Top assignees: Galileo Pharmaceuticals, Inc., Johnson & Johnson Consumer Companies, Inc., Monsanto Technology LLC. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sekhar S Boddupalli. Retrieved from https://idiyas.com/inventor/sekhar-s-boddupalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 42.9

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 198(Granted Patents)


Location History:

  • Manchester, MO (US) (2003 - 2010)
  • Palo Alto, CA (US) (2008 - 2010)
  • San Jose, CA (US) (2006 - 2011)
  • Manchester, MI (US) (2011)

Company Filing History:

goldMedal4 out of 9 
 
Galileo Pharmaceuticals, Inc.
 patents
silverMedal3 out of 271 
 
Johnson & Johnson Consumer Companies, Inc.
 patents
bronzeMedal3 out of 7,315 
 
Monsanto Technology LLC
 patents
4. 2 out of 90 
 
Carnegie Institution of Washington
 patents
5. 2 out of 3,289 
 
Monsanto Company
 patents
6. 1 out of 162 
 
Calgene Corporation
 patents
7. 1 out of 28 
 
Edison Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2003-2011

Loading Chart...
14 patents (USPTO):Explore Patents
1. 8003855 - Production of hydroxylated fatty acids in genetically modified plants (2011-08-23),
2. 7985771 - Furanone derivatives (2011-07-26),
3. 7781410 - Compositions containing chalcones and use thereof (2010-08-24),
4. 7709666 - Transgenic plants containing altered levels of sterol compounds and tocopherols (2010-05-04),
5. 7655777 - Nucleic acid molecules associated with the tocopherol pathway (2010-02-02),
6. 7629375 - Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods (2009-12-08),
7. 7514461 - Chroman derivatives (2009-04-07),
8. 7381433 - Compositions containing an extract of a primula denticulata and use thereof (2008-06-03),
9. 7119117 - Tocopherol enriched compositions and amelioration of inflammatory symptoms (2006-10-10),
10. 7081476 - Tocopherol enriched compositions for reducing IL6 levels (2006-07-25),
11. 7078541 - Benzofuran derivatives (2006-07-18),
12. 7034054 - Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols (2006-04-25),
13. 6936728 - Production of hydroxylated fatty acids in genetically modified plants (2005-08-30),
14. 6653530 - Methods for producing carotenoid compounds, tocopherol compounds, and specialty oils in plant seeds (2003-11-25),

Title: The Innovative Journey of Sekhar S Boddupalli

Introduction: Sekhar S Boddupalli, a talented inventor based in Manchester, MO (US), has made significant contributions to the field of innovations with his creative mindset and dedication to problem-solving.

Latest Patents: Sekhar S Boddupalli holds several patents in various technological domains, showcasing his versatility and expertise in inventing novel solutions to complex challenges.

Career Highlights: With a background in engineering and a passion for innovation, Sekhar S Boddupalli has a successful career marked by groundbreaking inventions that have had a positive impact on industries worldwide.

Collaborations: Throughout his career, Sekhar S Boddupalli has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Sekhar S Boddupalli's innovative spirit and commitment to pushing the boundaries of technology make him a respected figure in the world of inventions, with a promising future ahead in shaping the landscape of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…